Healio: Transcatheter pulmonic valve replacement system with adaptive prestent gains FDA approval The FDA gave the greenlight to transcatheter pulmonic valve replacement with the Sapien 3 system plus an adaptive pre-stent landing zone, dubbed Alterra, for patients with congenital heart disease. Nasdaq: Edwards Gets FDA Approval For SAPIEN 3 With Alterra For Transcatheter Pulmonic Valve Replacement Edwards Gets FDA Approval For SAPIEN 3 With Alterra For Transcatheter Pulmonic Valve Replacement Introduction In aortic valve disease, several interventions are available. In young people who are still growing, or considering the risks of long-term anticoagulation, the Ross procedure remains an ...
Please provide your email address to receive an email when new articles are posted on . Edwards Lifesciences announced it received FDA approval for its transcatheter valve with adaptive prestent for ... MedPage Today: Sapien 3 With Pre-Stent Gets FDA Go-Ahead for Pulmonary Valve Fix (RTTNews) - Edwards Lifesciences (EW) said it received approval from the U.S. Food and Drug Administration for the use of the Edwards SAPIEN 3 transcatheter valve with the Alterra adaptive prestent ...
